The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: A systematic review and meta-analysis of diagnostic test accuracy

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Xu, Xue Ying ^a   Kong, Hong ^a   Song, Rui Xiang ^b   Zhai, Yu Han ^a   Wu, Xiao Fei ^a   Ai, Wen Si ^a   Liu, Hong Bo ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FIBROSIS INDEX BASED ON THE 4 FACTORS; HEPATITIS B; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION TEST KIT; META ANALYSIS; PREDICTION; PREDICTIVE VALUE; QUESTIONNAIRE; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; COMPLICATION; METABOLISM;

BIOLOGICAL MARKERS; HEPATITIS B; HUMANS; LIVER CIRRHOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84903538828     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100182     Document Type: Review

References (62)

1. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, et al. (2004) Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38: S158-168.
2. Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY, et al. (1997) Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 145: 1039-1047.
3. Gumusay O, Ozenirler S, Atak A, Sonmez C, Ozkan S, et al. (2013) Diagnostic potential of serum direct markers and non-invasive fibrosis models in patients with chronic hepatitis B. Hepatol Res 43: 228-237.
4. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, et al. (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351: 1521-1531.
5. Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344: 495-500. (Pubitemid 32164902)
6. Colloredo G, Guido M, Sonzogni A, Leandro G (2003) Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 39: 239-244. (Pubitemid 36920560)
7. Kim BK, Kim do Y, Park JY, Ahn SH, Chon CY, et al. (2010) Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int 30: 546-553.
8. Sterling RK, Wegelin JA, Smith PG, Stravitz RT, Luketic VA, et al. (2010) Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samples. Clin Gastroenterol Hepatol 8: 1070-1076.
9. Poynard T, Morra R, Halfon P, Castera L, Ratziu V, et al. (2007) Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 7: 40.
10. Corradi F, Piscaglia F, Flori S, D'Errico-Grigioni A, Vasuri F, et al. (2009) Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography. Dig Liver Dis 41: 217-225.
11. Amorim TG, Staub GJ, Lazzarotto C, Silva AP, Manes J, et al. (2012) Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C. Ann Hepatol 11: 855-861.
12. Shaheen AA, Wan AF, Myers RP (2007) FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol 102: 2589-2600. (Pubitemid 47631778)
13. Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, et al. (2011) Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 53: 726-736.
14. Martinez SM, Fernandez-Varo G, Gonzalez P, Sampson E, Bruguera M, et al. (2011) Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C. Aliment Pharmacol Ther 33: 138-148.
15. Deeks JJ (2001) Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323: 157-162.
16. Chrysanthos NV, Papatheodoridis GV, Savvas S, Kafiri G, Petraki K, et al. (2006) Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis. Eur J Gastroenterol Hepatol 18: 389-396.
17. Wang H, Xue L, Yan R, Zhou Y, Wang MS, et al. (2013) Comparison of FIB-4 and APRI in Chinese HBV-infected patients with persistently normal ALT and mildly elevated ALT. J Viral Hepat 20: e3-10.
18. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
19. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3: 25.
20. Group TFMCS (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 20: 15-20.
21. Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19: 1409-1417.
22. Scheuer PJ (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13: 372-374.
23. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22: 696-699.
24. Strader DB, Wright T, Thomas DL, Seeff LB (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology 39: 1147-1171. (Pubitemid 38428955)
25. Walter SD (2002) Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 21: 1237-1256.
26. Moses LE, Shapiro D, Littenberg B (1993) Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12: 1293-1316. (Pubitemid 23230833)
27. Dukic V, Gatsonis C (2003) Meta-analysis of diagnostic test accuracy assessment studies with varying number of thresholds. Biometrics 59: 936-946. (Pubitemid 38021222)
28. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
29. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ (2004) A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 164: 1978-1984. (Pubitemid 39390553)
30. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, et al. (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58: 982-990. (Pubitemid 41316441)
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
32. Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58: 882-893. (Pubitemid 41115772)
33. Zhou K, Gao CF, Zhao YP, Liu HL, Zheng RD, et al. (2010) Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol 25: 1569-1577.
34. Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, et al. (2008) Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis 40: 267-274. (Pubitemid 351292341)
35. Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, et al. (2007) Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int 27: 969-976. (Pubitemid 47261951)
36. Hongbo L, Xiaohui L, Hong K, Wei W, Yong Z (2007) Assessing routine and serum markers of liver fibrosis in CHB patients using parallel and serial interpretation. Clin Biochem 40: 562-566. (Pubitemid 46601421)
37. Guzelbulut F, Sezikli M, Akkan-Cetinkaya Z, Yasar B, Ozkara S, et al. (2012) AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B. Turk J Gastroenterol 23: 353-358.
38. Lesmana CR, Salim S, Hasan I, Sulaiman AS, Gani RA, et al. (2011) Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting. J Clin Pathol 64: 916-920.
39. Seto WK, Lee CF, Lai CL, Ip PP, Fong DY, et al. (2011) A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B. PLoS One 6: e23077.
40. Liu XD, Wu JL, Liang J, Zhang T, Sheng QS (2012) Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients. World J Gastroenterol 18: 2784-2792.
41. Zhu X, Wang LC, Chen EQ, Chen XB, Chen LY, et al. (2011) Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection. Dig Dis Sci 56: 2742-2749.
42. Wu SD, Wang JY, Li L (2010) Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study. World J Gastroenterol 16: 501-507.
43. Wang Y, Xu MY, Zheng RD, Xian JC, Xu HT, et al. (2013) Prediction of significant fibrosis and cirrhosis in hepatitis B e-antigen negative patients with chronic hepatitis B using routine parameters. Hepatol Res 43: 441-451.
44. Ucar F, Sezer S, Ginis Z, Ozturk G, Albayrak A, et al. (2013) APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B. Eur J Gastroenterol Hepatol.
45. Basar O, Yimaz B, Ekiz F, Ginis Z, Altinbas A, et al. (2013) Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results. Clin Res Hepatol Gastroenterol 37: 152-158.
46. Liu HB, Zhou JP, Zhang Y, Lv XH, Wang W (2011) Prediction on liver fibrosis using different APRI thresholds when patient age is a categorical marker in patients with chronic hepatitis B. Clin Chim Acta 412: 33-37.
47. Sebastiani G, Vario A, Guido M, Alberti A (2007) Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 13: 525-531. (Pubitemid 46210918)
48. Bonnard P, Sombie R, Lescure FX, Bougouma A, Guiard-Schmid JB, et al. (2010) Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso. Am J Trop Med Hyg 82: 454-458.
49. Sebastiani G, Castera L, Halfon P, Pol S, Mangia A, et al. (2011) The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Alimentary Pharmacology & Therapeutics 34: 1202-1216.
50. Zhang YF, Shi H, Chen LB, Xu QH (2010) [Value of FIB-4 for the diagnosis of liver fibrosis in chronic hepatitis B]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 24: 215-217.
51. Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, et al. (2003) Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 39: 222-230. (Pubitemid 36920558)
52. Miailhes P, Pradat P, Chevallier M, Lacombe K, Bailly F, et al. (2011) Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients. J Viral Hepat 18: 61-69.
53. Bottero J, Lacombe K, Guechot J, Serfaty L, Miailhes P, et al. (2009) Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV coinfected patients. J Hepatol 50: 1074-1083.
54. Kim BK, Kim SU, Kim HS, Park JY, Ahn SH, et al. (2012) Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One 7: e35825.
55. Stibbe KJ, Verveer C, Francke J, Hansen BE, Zondervan PE, et al. (2011) Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Scand J Gastroenterol 46: 962-972.
56. Park MS, Kim BK, Cheong JY, Kim DJ, Park JY, et al. (2013) Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B. PLoS One 8: e55759.
57. Gui HL, Xie Q, Wang H (2008) [FibroTest-ActiTest for predicting liver fibrosis and inflammatory activity in Chinese patients with chronic hepatitis B]. Zhonghua Gan Zang Bing Za Zhi 16: 897-901.
58. Kim BK, Kim HS, Park JY, Kim do Y, Ahn SH, et al. (2012) Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One 7: e41964.
59. Sebastiani G, Castera L, Halfon P, Pol S, Mangia A, et al. (2011) The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther 34: 1202-1216.
60. Lavanchy D (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11: 97-107.
61. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, et al. (2001) Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357: 1069-1075. (Pubitemid 32322537)
62. Jin W, Lin Z, Xin Y, Jiang X, Dong Q, et al. (2012) Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol 12: 14.